Memorial Sloan Kettering Cancer Center

Certain patient demographics, including race and ethnicity and underlying primary malignant neoplasm, appeared associated with delays in cancer treatment among patients with COVID-19.

Oncology wasn’t the first love of Matthew D. Garrett, MD.

The Parker Institute for Cancer Immunotherapy presented $4.5 million in fellowship and scholarship awards to nine graduate and postdoctoral researchers.

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

Healio spoke with Fumiko Chino, MD, radiation oncologist at Memorial Sloan Kettering Cancer Center and winner of the Healio Patient Voice award, about the cost of cancer care and how it impacts treatment.

Within the past decade, data have emerged indicating an effective role of circulating tumor DNA in identifying lung cancer at an early stage and in matching patients with appropriate treatments.

Erica Fischer-Cartlidge, DNP, CNS, AOCNS, EBP-C, has been appointed chief clinical officer of Oncology Nursing Society.

President Joe Biden has appointed Elizabeth M. Jaffee, MD; Mitchel Berger, MD; and Carol L. Brown, MD, FACOG, FACS, to the President’s Cancer Panel, the White House announced in a press release.

The use of broad-spectrum antibiotics in the month leading up to chimeric antigen receptor T-cell therapy led to poorer outcomes and increased treatment-related toxicities, study results showed.

CHICAGO — Adding tiragolumab, an anti-TIGIT agent, to atezolizumab and carboplatin plus etoposide did not provide more benefit compared with atezolizumab and carboplatin plus etoposide alone, according to findings from SKYSCRAPER-02 trial.